• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者出院时的遵医态度。

Attitude towards adherence in patients with schizophrenia at discharge.

机构信息

Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Nussbaumstr. 7, 80336 Munich, Germany.

出版信息

J Psychiatr Res. 2009 Dec;43(16):1294-301. doi: 10.1016/j.jpsychires.2009.05.003. Epub 2009 Jun 7.

DOI:10.1016/j.jpsychires.2009.05.003
PMID:19505697
Abstract

BACKGROUND

Purpose of the present study was to assess the attitude towards adherence at discharge and to verify its predictability using anamnestic and sociodemographic variables, factors influencing clinical treatment as well as the medical treatment applied.

METHODS

Attitude towards adherence was evaluated in 369 inpatients with schizophrenic spectrum disorders within a naturalistic multicenter trial using the Compliance Rating Scale (CRS) by Kemp. Biweekly ratings of the PANSS, UKU and the Subjective Well-being under Neuroleptic Treatment Scale (SWN-K) were applied. Logistic regression and CART analyses were used to determine significant predictor variables for the attitude towards adherence at discharge.

RESULTS

Sixty-seven percent of the patients were rated to have an attitude of active participation and moderate participation (=positive attitude towards adherence) and 33% of the patients to have an attitude of passive acceptance, occasional or permanent reluctance towards treatment as well as refusing treatment (=negative attitude towards adherence). A significant correlation was found between patients with a positive attitude towards adherence and course of all PANSS subscales. Statistical analyses revealed a reduction in PANSS general psychopathology subscore, employment status, greater illness insight and treatment with atypical antipsychotics to be significantly predictive for a positive attitude towards adherence at discharge.

CONCLUSIONS

The importance of an adequate antipsychotic treatment as a precondition for a favourable adherence attitude and the need to incorporate adherence-focused psychotherapy and psychoeducation into daily clinical practice are highlighted.

摘要

背景

本研究旨在评估出院时的遵医态度,并通过病史和社会人口学变量、影响临床治疗的因素以及所应用的治疗方法来验证其可预测性。

方法

在一项自然主义的多中心试验中,我们使用 Kemp 的依从性评定量表(CRS)评估了 369 例精神分裂症谱系障碍住院患者的遵医态度。每周两次评定 PANSS、UKU 和神经阻滞剂治疗下的主观幸福感量表(SWN-K)。采用逻辑回归和 CART 分析确定出院时遵医态度的显著预测变量。

结果

67%的患者被评定为具有积极参与和适度参与的态度(=遵医态度积极),33%的患者具有被动接受、偶尔或持续抗拒治疗以及拒绝治疗的态度(=遵医态度消极)。遵医态度积极的患者与所有 PANSS 子量表的病程呈显著相关。统计分析显示,PANSS 一般精神病学子量表评分降低、就业状况、更高的疾病认识和使用非典型抗精神病药物治疗对出院时的遵医态度具有显著预测作用。

结论

强调了充分的抗精神病治疗作为良好遵医态度的前提的重要性,以及将以遵医为重点的心理治疗和心理教育纳入日常临床实践的必要性。

相似文献

1
Attitude towards adherence in patients with schizophrenia at discharge.精神分裂症患者出院时的遵医态度。
J Psychiatr Res. 2009 Dec;43(16):1294-301. doi: 10.1016/j.jpsychires.2009.05.003. Epub 2009 Jun 7.
2
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.抗精神病药物依从性评估中患者与临床医生观点的比较。
Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973. Epub 2009 Aug 11.
3
[Relationships between insight and medication adherence in subjects with psychosis].[精神病患者领悟与药物依从性之间的关系]
Encephale. 2003 Sep-Oct;29(5):430-7.
4
How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.社会人口学和临床因素如何与精神分裂症的依从态度特征相互作用?一种聚类分析方法。
Psychiatry Res. 2011 May 15;187(1-2):55-61. doi: 10.1016/j.psychres.2010.10.012. Epub 2010 Nov 12.
5
Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors.门诊抗精神病药物治疗中的协作:潜在影响因素分析
Psychiatry Res. 2008 Nov 30;161(2):225-34. doi: 10.1016/j.psychres.2007.07.027. Epub 2008 Oct 14.
6
Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.精神分裂症患者中抗精神病药物的主观副作用与药物依从性
J Adv Nurs. 2009 Mar;65(3):534-43. doi: 10.1111/j.1365-2648.2008.04906.x.
7
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?精神分裂症和精神分裂症谱系障碍的生活质量和主观幸福感:症状反应和缓解的有效预测因子?
World J Biol Psychiatry. 2010 Aug;11(5):729-38. doi: 10.3109/15622971003690289.
8
Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.精神分裂症患者的生活质量:精神病理学、对药物治疗的态度及副作用的影响
J Clin Psychiatry. 2004 Jul;65(7):932-9.
9
[Drug compliance and health locus of control in schizophrenia].[精神分裂症患者的药物依从性与健康控制点]
Encephale. 2011 May;37 Suppl 1:S11-8. doi: 10.1016/j.encep.2010.08.007. Epub 2010 Oct 8.
10
The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.四点序贯联盟自评量表:一种用于评估常规心理健康治疗关系的自评问卷。
Compr Psychiatry. 2009 Mar-Apr;50(2):181-5. doi: 10.1016/j.comppsych.2008.06.010. Epub 2008 Aug 23.

引用本文的文献

1
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.使用鲁拉西酮治疗的患者长期健康相关生活质量改善情况:精神分裂症转换试验开放标签扩展研究的结果
BMC Psychiatry. 2016 Jun 1;16:176. doi: 10.1186/s12888-016-0879-5.
2
The Promises and Challenges of Ecological Momentary Assessment in Schizophrenia: Development of an Initial Experimental Protocol.精神分裂症生态瞬时评估的前景与挑战:初步实验方案的制定
Healthcare (Basel). 2015 Sep;3(3):556-73. doi: 10.3390/healthcare3030556. Epub 2015 Jul 15.
3
Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone.
精神病患者的药物依从性:一项针对患者改用长效注射用利培酮之前的观察性调查。
Patient Prefer Adherence. 2015 Sep 16;9:1333-41. doi: 10.2147/PPA.S89748. eCollection 2015.
4
[Risk factors for treatment adherence in patients with schizophrenia: case-control study].[精神分裂症患者治疗依从性的危险因素:病例对照研究]
Pan Afr Med J. 2015 Mar 20;20:273. doi: 10.11604/pamj.2015.20.273.3380. eCollection 2015.
5
Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.基于证据的预防和治疗首发精神病的心理治疗
Eur Arch Psychiatry Clin Neurosci. 2014 Nov;264 Suppl 1:S17-25. doi: 10.1007/s00406-014-0538-0. Epub 2014 Sep 27.
6
Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications.使用第一代或第二代药物治疗的精神分裂症患者对抗精神病药物的态度。
Indian J Psychol Med. 2014 Jul;36(3):288-93. doi: 10.4103/0253-7176.135382.
7
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.接受鲁拉西酮治疗患者的健康相关生活质量:来自一项精神分裂症患者换药试验的结果。
BMC Psychiatry. 2014 Feb 23;14:53. doi: 10.1186/1471-244X-14-53.
8
Antipsychotic agents: efficacy and safety in schizophrenia.抗精神病药物:在精神分裂症中的疗效与安全性。
Drug Healthc Patient Saf. 2012;4:173-80. doi: 10.2147/DHPS.S37429. Epub 2012 Nov 29.
9
Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder.短期临床稳定性和自知力缺失与精神分裂症和双相情感障碍患者出院时对抗精神病药物治疗的消极态度相关。
Patient Prefer Adherence. 2012;6:623-9. doi: 10.2147/PPA.S34345. Epub 2012 Aug 29.
10
Social interaction and drug attitude effectiveness in patients with schizophrenia.社交互动和药物态度对精神分裂症患者的影响。
Psychiatr Q. 2011 Dec;82(4):343-51. doi: 10.1007/s11126-011-9177-z.